NCT07270263 2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA Recruiting
Clinical Trials
13 trialsNCT06220123 2025-07-22
A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 2 Completed
NCT06580223 2025-07-18
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3 Not yet recruiting
NCT05920343 2025-07-10
PREVENT-GU
Ottawa Hospital Research Institute
Phase 2/3 Recruiting
NCT05029063 2025-07-09
TRIM-Line
Ottawa Hospital Research Institute
Phase 3 Recruiting
NCT06314763 2024-04-30
ROSIE
Radboud University Medical Center
Phase 4 Completed
NCT06196918 2024-01-09
Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients
Nanfang Hospital, Southern Medical University
Phase NA Unknown
NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT03055026 2022-03-11
PRO-LAPSII
Fadoi Foundation, Italy
Phase 3 Completed
NCT04999176 2021-08-10
VALERIA
Science Valley Research Institute
Phase 3 Unknown
NCT02583191 2021-05-03
Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients
AIO-Studien-gGmbH
Phase 3 Terminated
NCT02555878 2019-09-12
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Janssen Research & Development, LLC
Phase 3 Completed
NCT02746185 2018-08-13
CASTA-DIVA
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed